Paladina Health Announces New Chief Medical Officer During Annual Provider Summit

In addition to Dr. Barker’s appointment, Paladina Health also recently announced their acquisition by New Enterprise Associates (NEA), as well as a …

DENVER, Oct. 23, 2018 /PRNewswire/ —Paladina Health, a leading-edge healthcare provider whose model improves patient care and satisfaction while lowering costs, today announced Tobias Barker, MD, MHCM as the company’s new Chief Medical Officer. Paladina Health offers a patient-first approach to primary care, including unhurried appointments, 24/7 physician access for urgent needs, referral management and care coordination, and no or low co-pays.

A board-certified physician of over 15 years, Dr. Barker most recently held the role of Vice President, Medical Operations and Chief Medical Officer of CVS MinuteClinic where he oversaw all clinical care delivered at over 1,100 clinics within 34 states. Dr. Barker led initiatives to provide telemedicine capabilities nationwide and was responsible for developing partnerships and collaborations with health systems to jointly manage patients in the chronic care space including a first-of-its-kind partnership between the Department of Veteran Affairs and CVS. As CMO at Paladina Health, he will lead the network of providers and medical directors, and continue to shape the overall medical and clinical direction of the organization.

“We are extremely proud of the culture at Paladina Health, a company driven by our vision to be the leader in transforming primary care in America. Throughout our search for a Chief Medical Officer, we emphasized the need for someone with a strong clinical background who demonstrates a passion for exceptional patient care in addition to building and growing a strong, cohesive team,” said Chris Miller, MBA, Chief Executive Officer of Paladina Health. “We are thrilled that Dr. Barker is joining Paladina Health as Chief Medical Officer. In addition to being a practicing physician, he has comprehensive experience in patient-first clinical strategy and operations, most recently through his role as CMO for CVS MinuteClinic.”

The announcement of Dr. Barker’s appointment comes during Paladina Health’s annual Provider Summit, held in Denver, which includes the company’s physicians, nurse practitioners, and physician assistants. This gathering serves as a face-to-face opportunity for the company’s care teams to discuss clinical best practices, service delivery, continuing education, and changes within the broader medical community. In addition, the Provider Summit stands as an opportunity to recognize Paladina Health’s clinical team for the outstanding care they deliver to patients across the U.S.

“This is a very exciting time for Paladina Health and I am extremely proud to join the team,” said Dr. Barker. “In addition to retaining a focus on patient-first care, I look forward to applying my experience and expertise in building high-performing teams and implementing clinical innovations to positively impact Paladina Health’s already successful trajectory.”

Previously, Dr. Barker served as the Director of Physician and Nursing Education for the Harvard Medical School Dubai Center. He earned his medical degree from the David Geffen School of Medicine at UCLA, where he also received the prestigious Howard Hughes research scholarship. In addition, he was recently awarded a Master’s degree in Healthcare Management from the Harvard School of Public Health.

In addition to Dr. Barker’s appointment, Paladina Health also recently announced their acquisition by New Enterprise Associates (NEA), as well as a follow-on financing round from NEA, Oak HC/FT, Alta Partners, Greenspring Associates and other strategic investors. The company currently operates doctors’ offices in Colorado, Washington, Wisconsin, Ohio, North Carolina, South Carolina, Kentucky, New Jersey and Florida, with plans for continued expansion.

About Paladina Health

Paladina Health is a physician-access model of health care that improves patient care and satisfaction by providing convenient and unhurried patient-centered care and a broad scope of services. Employers who offer Paladina Health to their employees aim to provide the highest-quality benefits while keeping a long-range view of improving the health and wellness of their covered population. For more information, visit https://www.paladinahealth.com.

SOURCE Paladina Health

Related Links

http://www.paladinahealth.com

Related Posts:

  • No Related Posts

‘The first tunnel is almost done,’ says SpaceX CEO Elon Musk; Five facts Musk’s plan

Tesla and SpaceX CEO Elon Musk has said that he was planning to offer the public free rides through a tunnel he bored under a Los Angeles suburb …
In a series of tweets, Musk said the tunnel is almost complete and there will be an opening event on the night of December 10 and free rides for the public the next day. (Reuters)

Tesla and SpaceX CEO Elon Musk has said that he was planning to offer the public free rides through a tunnel he bored under a Los Angeles suburb to test a new type of transportation system.

In a series of tweets, Musk said the tunnel is almost complete and there will be an opening event on the night of December 10 and free rides for the public the next day.

The first tunnel is almost done

— Elon Musk (@elonmusk) October 22, 2018

Opens Dec 10

— Elon Musk (@elonmusk) October 22, 2018

The tunnel reportedly runs about 2 miles (3.2 kilometres) under the streets of Hawthorne in the Los Angeles area. The area houses the SpaceX headquarters. Musk has described a system in which vehicles or people pods are moved on electrically powered platforms called skates at speeds up to 155 mph (250 kph), news agency AP reported.

Here are the five interesting facts about the Musk’s plan:

1) The tunnel boring machine, named Godot, has successfully dug a tunnel on SpaceX’s parking lot at the intersection of Crenshaw Boulevard and Rocket Road in Los Angeles. This machine was also used for a sewer project in Sunnydale, California.

2) Musk would want to explore a tunnelling system that integrates cars in a city like Los Angeles. The Boring Company, however, is exploring ways to use tunnels to support a high-speed rail or Hyperloop.

3) As per plans, the electric skate would transport cars through the tunnel at speeds up to 130 mph, Musk has said. It could also transport passenger cars so pedestrians could use the tunnel system.

4) The SpaceX tunnel is being used to test Musk’s futuristic car skate.

5) Musk said the Boring Company plans to dig a tunnel that would support a Hyperloop between New York and Washington DC.

Earlier, Musk has said that his tunnelling company “started out as a joke”. The company has also touted plans to build a tunnel across western Los Angeles and another between a Metro subway line and Dodger Stadium.

Related Posts:

  • No Related Posts

Peter Thiel-Backed Synthego Raises $110 Million

… have raised an amount of $110 Million in the fresh funding in cash from the new investors at the Founders Fund and the company previous investors …

Paul Dabrowski, the CEO of the Synthego, which helps the companies in providing the genetically engineered cells to researchers and scientist, who worries more about the future where access to the genetic technologies will reshape the world.

“People talk about access to the tools, but the question is access to the therapies,” Dabrowski said. “We’re talking about the basis of what does it mean to be human not right now, but in the next 100 years.”

Today, in a reporting company has announced that they have raised an amount of $110 Million in the fresh funding in cash from the new investors at the Founders Fund and the company previous investors, that is Menlo ventures and 8VC.

“This new funding allows us to expand our reach and build out of our full stack platform capabilities at a perfect time,” said Dabrowski, co-founder, and CEO, Synthego, in a statement. “Biological medicines are on the cusp of a revolution with the coming curative cell and gene therapies, and we are proud to support this industry.”

The company revealed that the new funding would be going to be used for further development and research, by bringing new services to the market. In the near term, the funding is also going to be used to expand the two main areas of the company interest. One is the creation of CRISPR kits that can create the genetic lines which are based on the requests from the scientist and researchers and the other is creating materials that are “clinical-grade,” which means that they can be used easily in the clinical trials on an animal.

“In general the demand for these products is quite high. Building capacity and building out the informatics models for the predictability on the CRISPR research side.

The Redwood City which is a California based company has also raised $166 Million in the funding round to develop its latest innovative technology which makes the development and research using the gene editing tools which is known as CRISPR. As we’d written previously, Synthego launched its first CRISPR offerings to the market earlier this year.

You may also like:

Wallarm Raises $8M To Boost Application Security Platform

Related Posts:

  • No Related Posts

Millennium Management LLC Has $2.84 Million Stake in Bright Scholar Education Holdngs Ltd …

Millennium Management LLC lessened its position in Bright Scholar Education Holdngs Ltd-ADR (NYSE:BEDU) by 50.9% in the 2nd quarter, …

Bright Scholar Education Holdngs logoMillennium Management LLC lessened its position in Bright Scholar Education Holdngs Ltd-ADR (NYSE:BEDU) by 50.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 170,894 shares of the company’s stock after selling 176,959 shares during the quarter. Millennium Management LLC owned 0.13% of Bright Scholar Education Holdngs worth $2,842,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company acquired a new position in Bright Scholar Education Holdngs during the first quarter worth approximately $6,948,000. Guggenheim Capital LLC increased its position in Bright Scholar Education Holdngs by 36.1% during the first quarter. Guggenheim Capital LLC now owns 24,423 shares of the company’s stock worth $377,000 after buying an additional 6,474 shares during the last quarter. Point72 Asset Management L.P. acquired a new position in Bright Scholar Education Holdngs during the first quarter worth approximately $1,081,000. Bank of Montreal Can increased its position in Bright Scholar Education Holdngs by 58.8% during the second quarter. Bank of Montreal Can now owns 24,999 shares of the company’s stock worth $416,000 after buying an additional 9,260 shares during the last quarter. Finally, Hikari Power Ltd acquired a new position in Bright Scholar Education Holdngs during the second quarter worth approximately $268,000. Hedge funds and other institutional investors own 13.19% of the company’s stock.

BEDU has been the subject of a number of research analyst reports. TheStreet cut Bright Scholar Education Holdngs from a “c-” rating to a “d” rating in a report on Monday, August 13th. Zacks Investment Research cut Bright Scholar Education Holdngs from a “hold” rating to a “sell” rating in a report on Thursday, October 4th. ValuEngine cut Bright Scholar Education Holdngs from a “hold” rating to a “sell” rating in a report on Wednesday, September 12th. Finally, Morgan Stanley cut Bright Scholar Education Holdngs from an “overweight” rating to an “equal weight” rating in a report on Tuesday, October 2nd. One analyst has rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company. The company has an average rating of “Hold” and an average target price of $17.00.

Shares of NYSE:BEDU opened at $10.54 on Tuesday. Bright Scholar Education Holdngs Ltd-ADR has a 12-month low of $9.13 and a 12-month high of $26.62. The company has a market cap of $1.29 billion, a PE ratio of 35.07 and a beta of 1.31.

Bright Scholar Education Holdngs (NYSE:BEDU) last issued its quarterly earnings data on Tuesday, July 24th. The company reported $0.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.03). Bright Scholar Education Holdngs had a return on equity of 12.61% and a net margin of 14.37%. The firm had revenue of $84.39 million for the quarter. On average, equities research analysts expect that Bright Scholar Education Holdngs Ltd-ADR will post 0.31 EPS for the current year.

Bright Scholar Education Holdngs Company Profile

Bright Scholar Education Holdings Limited operates K-12 schools in China. Its schools comprise international schools, bilingual schools, and kindergartens. The company also offers a range of complementary education services, including international camps and after-school programs. As of May 31, 2018, it had a network of 67 schools with approximately 35,275 students.

Further Reading: How much money do you need to begin day trading?

Want to see what other hedge funds are holding BEDU?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bright Scholar Education Holdngs Ltd-ADR (NYSE:BEDU).

Institutional Ownership by Quarter for Bright Scholar Education Holdngs (NYSE:BEDU)

Receive News & Ratings for Bright Scholar Education Holdngs Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bright Scholar Education Holdngs and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts